Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases
作者： Alan J Grodzinsky , N. N. Rahbari , D. Fukumura , C. Reissfelder , J. Daubriac
DOI:
关键词:
摘要: The survival benefit of anti–vascular endothelial growth factor (VEGF) therapy in metastatic colorectal cancer (mCRC) patients is limited to a few months because of acquired resistance. …
参考文章(0)